Luca Quagliata
Thermo Fisher Scientific (United States)(US)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Cancer-related molecular mechanisms research, Hepatocellular Carcinoma Treatment and Prognosis, Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients(2013)441 cited
- → Parallel T-cell cloning and deep sequencing of human MAIT cells reveal stable oligoclonal TCRβ repertoire(2014)307 cited
- → The protein histidine phosphatase LHPP is a tumour suppressor(2018)263 cited
- → Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer(2014)220 cited
- → Human and Mouse VEGFA -Amplified Hepatocellular Carcinomas Are Highly Sensitive to Sorafenib Treatment(2014)184 cited
- → A link between inflammation and metastasis: serum amyloid A1 and A3 induce metastasis, and are targets of metastasis-inducing S100A4(2014)158 cited
- → Hepatic mTORC1 controls locomotor activity, body temperature, and lipid metabolism through FGF21(2014)151 cited
- → Cancer Diagnosis Using a Liquid Biopsy: Challenges and Expectations(2018)137 cited
- → Cell-free DNA analysis in healthy individuals by next-generation sequencing: a proof of concept and technical validation study(2019)128 cited
- → Tumor mutational burden assessed by targeted NGS predicts clinical benefit from immune checkpoint inhibitors in non‐small cell lung cancer(2019)114 cited